PROTEOMICS, EarlyView.ABSTRACT Chronic kidney disease (CKD) poses a significant and growing global health challenge, making early detection and slowing disease progression essential for improving patient outcomes. Traditional diagnostic methods such as glomerular filtration rate and proteinuria are insufficient to capture the complexity of CKD.
Marta B. Lopes +9 more
wiley +1 more source
Effects of glycemic indicators on early neurological outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. [PDF]
World J DiabetesDuan ZW +8 more
europepmc +1 more source
Positive association between stress hyperglycemia ratio and ICU mortality in patients with pulmonary embolism: A retrospective study. [PDF]
PLoS OneLiao J, Lu D, Wang M, Yu H.
europepmc +1 more source
Association of Serum Uric Acid Levels with Cardiometabolic Factors in Adolescents with Obesity: A Cross-Sectional Study. [PDF]
MetabolitesVillasis-Keever MA +7 more
europepmc +1 more source
Increased Expression of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Brain of Chronic Diabetic Rats. [PDF]
SynapsePazarlar BA +3 more
europepmc +1 more source
Impact of different doses of intravenous alteplase on neuroinjury biomarker levels in patients with acute ischemic stroke and stress hyperglycemia. [PDF]
Medicine (Baltimore)Yang W, Chen W, Lu S.
europepmc +1 more source
An exposure-safety analysis to support the dosage of the novel AKT inhibitor capivasertib. [PDF]
Cancer Chemother PharmacolTeruel CF +4 more
europepmc +1 more source
Related searches:
I. Compatible method, a new mode of control, is advocated in helping to guide diabetic therapy because: (a)53% of our group of 100 patients discontinued insulin for an average period, which has existed for 2 years and 8 months. This latter period for the individual patient varied from 2 months to 9 years and 6 months.
Frank A. Bove +3 more
openaire +3 more sources
Pharmacotherapy of hyperglycemia
Expert Opinion on Pharmacotherapy, 2009Type 2 diabetes mellitus (T2DM) is a chronic, progressive disorder that affects more than 230 million people worldwide and is expected to affect 366 million by 2030. Both the prevalence of T2DM and the cost of its long term complications has driven the focus and emphasis on treatments aimed at reducing hyperglycemia and controlling hypertension and ...
Robert R. Henry, Kristen Kulasa
openaire +3 more sources
Diabetes mellitus and its complications are among the leading causes of organ failure around the world. It is imperative that timely, patient-centered care is provided to avoid microvascular and macrovascular damage. People with well-controlled diabetes can live long and healthy lives through interprofessional management, emphasizing optimal ...
Kathryn Evans, Kreider +2 more
openaire +2 more sources